ConductScience.org, home

Paper8096066

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.

Small PM and 7 others. N Engl J Med, 1993. Cited by 436 papers, by iCite.

Cite this record

ConductScience Library. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. Papers, record 8096066. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8096066

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.
PubMed
Journal
N Engl J Med
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
436
iCite
Relative citation ratio, by iCite
15.7
iCite
Revised in PubMed
2010-03-24
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Small PMP M
2Shafer RWR W
3Hopewell PCP C
4Singh SPS P
5Murphy MJM J
6Desmond EE
7Sierra MFM F
8Schoolnik GKG K

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS-Related Opportunistic InfectionsMajor topic
Antitubercular AgentsMajor topic
Mycobacterium tuberculosisMajor topic
Tuberculosis, PulmonaryMajor topic
Adult
DNA, Bacterial
Drug Resistance, Microbial
Female
Humans
Male
Middle Aged
Polymorphism, Restriction Fragment Length
Recurrence

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI07089-11NIAID NIH HHSUnited StatesPubMedPubMed
AI27762-03NIAID NIH HHSUnited StatesPubMedPubMed
P30AI027762NIHNIH RePORTER
T32AI007089NIHNIH RePORTER

Download CSV of grants

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in8350906Reinfection with multidrug-resistant tuberculosis.https://conductscience.org/library/papers/8350906PubMed
Comment in8350907Reinfection with multidrug-resistant tuberculosis.https://conductscience.org/library/papers/8350907PubMed
Comment in8455687A tale of two mutants.https://conductscience.org/library/papers/8455687PubMed

Download CSV of comments and corrections

Cited by111

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 436 citations.

PMIDTitleJournalYearIn PapersSource
40406648Tuberculosis Trends in the Post-COVID-19 Era: Is It Going to be a Global Concern?Health Sci Rep2025https://conductscience.org/library/papers/40406648PubMed
36966312In silico characterization of cysteine-stabilized αβ defensins from neglected unicellular microeukaryotes.BMC Microbiol2023https://conductscience.org/library/papers/36966312PubMed
31720407Molecular genotyping to differentiate endogenous reactivation and exogenous reinfection of recurrent tuberculosis.J Clin Tuberc Other Mycobact Dis2018https://conductscience.org/library/papers/31720407PubMed
31233535Genetic diversity and drug susceptibility profiles of Mycobacterium tuberculosis obtained from Saint Peter's TB specialized Hospital, Ethiopia.PLoS One2019https://conductscience.org/library/papers/31233535PubMed
30730960Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization.PLoS One2019https://conductscience.org/library/papers/30730960PubMed
30554996Transmission of drug-resistant tuberculosis in HIV-endemic settings.Lancet Infect Dis2019https://conductscience.org/library/papers/30554996PubMed
29649213New insights into the transposition mechanisms of IS6110 and its dynamic distribution between Mycobacterium tuberculosis Complex lineages.PLoS Genet2018https://conductscience.org/library/papers/29649213PubMed
28790676PREVALENCE OF DRUG RESISTANT TUBERCULOSIS IN ARMED FORCES-STUDY FROM A TERTIARY REFERRAL CHEST DISEASES HOSPITAL AT PUNE.Med J Armed Forces India2000https://conductscience.org/library/papers/28790676PubMed
27688532Resistance to Antituberculosis Drugs in Pulmonary Tuberculosis.Med J Armed Forces India2006https://conductscience.org/library/papers/27688532PubMed
27516382Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.Clin Infect Dis2016https://conductscience.org/library/papers/27516382PubMed
27502557Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis.Elife2016https://conductscience.org/library/papers/27502557PubMed
27382565Comparative Analysis of Human B Cell Epitopes Based on BCG Genomes.Biomed Res Int2016https://conductscience.org/library/papers/27382565PubMed
26504253Foreign-Born Status and Geographic Patterns of Tuberculosis Genotypes in Tarrant County, Texas.Prof Geogr2007https://conductscience.org/library/papers/26504253PubMed
25300708Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.BMC Infect Dis2014https://conductscience.org/library/papers/25300708PubMed
25190252Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches.Cold Spring Harb Perspect Med2014https://conductscience.org/library/papers/25190252PubMed
24454706Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.PLoS One2014https://conductscience.org/library/papers/24454706PubMed
23640554Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.Indian J Med Res2013https://conductscience.org/library/papers/23640554PubMed
23555576A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis.PLoS One2013https://conductscience.org/library/papers/23555576PubMed
23223590Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.Clin Infect Dis2013https://conductscience.org/library/papers/23223590PubMed
23145087HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.PLoS One2012https://conductscience.org/library/papers/23145087PubMed

See all 111 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8096066

GET https://conductscience.org/api/papers/v1/8096066/cited_by?page=2